Actively Recruiting
Residual Embolism Evaluated With Single Photon Emission Computed Tomography
Led by Centre Hospitalier Universitaire de Saint Etienne · Updated on 2025-08-07
358
Participants Needed
1
Research Sites
91 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Major progress achieved in diagnostic and therapeutic strategies has substantially improved the short-term prognosis of patients with pulmonary embolism (PE). These improvements have led to a shift from an acute to a chronic condition of venous thromboembolism, justifying the recent development of Chronic Thrombo-embolic Disease (CTED). In most of the situations, it is due to a residual pulmonary vascular obstruction (RPVO) which can be assessed by pulmonary scintigraphy.
CONDITIONS
Official Title
Residual Embolism Evaluated With Single Photon Emission Computed Tomography
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient referred to the nuclear medicine department of Saint-Etienne public hospital for V/Q pulmonary SPECT-CT to check for lung blood flow blockage, suspected pulmonary hypertension, or persistent breathlessness after pulmonary embolism
- Patient is affiliated with or a beneficiary of social security
You will not qualify if you...
- Pregnant patients
- Patients referred for acute pulmonary embolism
- Unable to complete the entire scan protocol
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre Hospitalier Universitaire
Saint-Etienne, France, 42055
Actively Recruiting
Research Team
P
Pierre-Benoit BONNEFOY, MD
CONTACT
N
NATHALIE PREVOT, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here